Piétu G - Search Results

1

Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries.

Piétu G, Ribba AS, Chérel G, Siguret V, Obert B, Rouault C, Ginsburg D, Meyer D. Piétu G, et al. Thromb Haemost. 1994 Jun;71(6):788-92. Thromb Haemost. 1994. PMID: 7974349

2

Epitope mapping by cDNA expression of a monoclonal antibody which inhibits the binding of von Willebrand factor to platelet glycoprotein IIb/IIIa.

Piétu G, Ribba AS, Chérel G, Meyer D. Piétu G, et al. Biochem J. 1992 Jun 15;284 ( Pt 3)(Pt 3):711-5. doi: 10.1042/bj2840711. Biochem J. 1992. PMID: 1377911 Free PMC article.

3

Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.

Lavergne JM, De Paillette L, Bahnak BR, Ribba AS, Fressinaud E, Meyer D, Pietu G. Lavergne JM, et al. Among authors: pietu g. Br J Haematol. 1992 Sep;82(1):66-72. doi: 10.1111/j.1365-2141.1992.tb04595.x. Br J Haematol. 1992. PMID: 1419804

4

Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.

Piétu G, Ribba AS, de Paillette L, Chérel G, Lavergne JM, Bahnak BR, Meyer D. Piétu G, et al. Blood Coagul Fibrinolysis. 1992 Aug;3(4):415-21. Blood Coagul Fibrinolysis. 1992. PMID: 1420817

5

Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease.

Ribba AS, Voorberg J, Meyer D, Pannekoek H, Pietu G. Ribba AS, et al. Among authors: pietu g. J Biol Chem. 1992 Nov 15;267(32):23209-15. J Biol Chem. 1992. PMID: 1429668 Free article.

6

von Willebrand factor: structure and function.

Meyer D, Piétu G, Fressinaud E, Girma JP. Meyer D, et al. Among authors: pietu g. Mayo Clin Proc. 1991 May;66(5):516-23. doi: 10.1016/s0025-6196(12)62394-5. Mayo Clin Proc. 1991. PMID: 1903172 Review.

7

Localization within the 106 N-terminal amino acids of von Willebrand factor (vWF) of the epitope corresponding to a monoclonal antibody which inhibits vWF binding to factor VIII.

Piétu G, Ribba AS, Meulien P, Meyer D. Piétu G, et al. Biochem Biophys Res Commun. 1989 Aug 30;163(1):618-26. doi: 10.1016/0006-291x(89)92182-7. Biochem Biophys Res Commun. 1989. PMID: 2476129

8

Production in Escherichia coli of a biologically active subfragment of von Willebrand factor corresponding to the platelet glycoprotein Ib, collagen and heparin binding domains.

Piétu G, Meulien P, Cherel G, Diaz J, Baruch D, Courtney M, Meyer D. Piétu G, et al. Biochem Biophys Res Commun. 1989 Nov 15;164(3):1339-47. doi: 10.1016/0006-291x(89)91816-0. Biochem Biophys Res Commun. 1989. PMID: 2686638

9

Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domain.

Jorieux S, Gaucher C, Piétu G, Chérel G, Meyer D, Mazurier C. Jorieux S, et al. Among authors: pietu g. Br J Haematol. 1994 May;87(1):113-8. doi: 10.1111/j.1365-2141.1994.tb04879.x. Br J Haematol. 1994. PMID: 7524613

10

A monoclonal antibody (B724) to von Willebrand factor recognizing an epitope within the A1 disulphide loop (Cys509-Cys695) discriminates between type 2A and type 2B von Willebrand disease.

Christophe O, Rouault C, Obert B, Piétu G, Meyer D, Girma JP. Christophe O, et al. Among authors: pietu g. Br J Haematol. 1995 May;90(1):195-203. doi: 10.1111/j.1365-2141.1995.tb03400.x. Br J Haematol. 1995. PMID: 7540413 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters